The Solidarity Trial showed that the drug is ineffective in reducing COVID-19 mortality
Gilead Sciences, manufacturer of remdesivir calls the WHO trial inconsistent and needing more rigorous review
Covid-19 life-saving drugs Tocilizumab and Remdesivir are not easily available for relatives of patients who might need...
How will the India-China border dispute affect local and export pharma industry in India?
An Oxford study has hailed dexamethasone, a steroid, as a wonder drug to help critically ill COVID-19 patients.
The US FDA has only authorised the emergency use of remdesivir in treating COVID-19 patients in hospitals.